Drug Type Small molecule drug |
Synonyms Methylprednisolone Hemisuccinate, Methylprednisolone hydrogen succinate, Methylprednisolone sodium succinate (JAN/USP) + [10] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 May 1959), |
Regulation- |
Molecular FormulaC26H34NaO8 |
InChIKeyWOARBZBOZOGFGA-SGJOWKDISA-N |
CAS Registry2375-03-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Mucocutaneous Lymph Node Syndrome | JP | 25 Sep 2023 | |
Churg-Strauss Syndrome | JP | 29 Aug 2014 | |
Granulomatosis With Polyangiitis | JP | 29 Aug 2014 | |
Polyarteritis Nodosa | JP | 29 Aug 2014 | |
Polymyositis | JP | 29 Aug 2014 | |
Systemic Lupus Erythematosus | JP | 29 Aug 2014 | |
Takayasu Arteritis | JP | 29 Aug 2014 | |
Lymphoma | JP | 29 Aug 2001 | |
Nephrotic Syndrome | JP | 29 Aug 2001 | |
Spinal Cord Injuries | JP | 29 Aug 2001 | |
Systemic Vasculitis | JP | 29 Aug 2001 | |
Addison Disease | CN | 01 Jan 2001 | |
Anemia | CN | 01 Jan 2001 | |
Asthma | CN | 01 Jan 2001 | |
Dermatomyositis | CN | 01 Jan 2001 | |
Keratitis | CN | 01 Jan 2001 | |
Leukemia | CN | 01 Jan 2001 | |
Multiple Sclerosis | CN | 01 Jan 2001 | |
Pemphigus | CN | 01 Jan 2001 | |
acute spinal cord injury | JP | 02 Jul 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria, Falciparum | Preclinical | IL | - | |
Optic Neuritis | Preclinical | IL | - | |
Rheumatoid Arthritis | Preclinical | IL | - |
Phase 4 | 89 | Low Dose Corticosteroids (Low Dose Corticosteroids) | bqpigtlgmf(hlqlnwhons) = lkobyixnoo wcvlnorurj (ukdbhxjkjr, ubzmfuucdr - jdyztbcyzl) View more | - | 10 Apr 2024 | ||
High Dose Corticosteroids (High Dose Corticosteroids) | bqpigtlgmf(hlqlnwhons) = fqbdvlsmuy wcvlnorurj (ukdbhxjkjr, pqtphytdhp - injbullsst) View more | ||||||
Early Phase 1 | 47 | (Group A: Glucocorticoids 1 mg/kg Dose) | uqgyxcgknu(mjjcdwppqi) = lxcuocxcyp ryxchytoem (idhhighgbh, tprqvmlbij - gmzphhwneu) View more | - | 21 Aug 2023 | ||
(Group B: Glucocorticoids 250 mg Dose) | uqgyxcgknu(mjjcdwppqi) = sollreyecp ryxchytoem (idhhighgbh, ogvdcqwxmf - zttverzpzg) View more | ||||||
Phase 1 | - | 33 | (Up to 2 Hours Post Infusion) | nuxlavfggk(tlotqzfael) = pjbizfrdsx yvhfepkgla (vqfhinlywx, xprlvtjyqa - rdyywscsst) View more | - | 22 Jun 2023 | |
Methylprednisolone sodium succinate(Solu-Medrol)+Topical methylprednisolone (Advantan emulsion 0 /1%) (Up to 4 Hours Post Infusion) | nuxlavfggk(tlotqzfael) = vfhweyqpgu yvhfepkgla (vqfhinlywx, oujeewaczn - oaznszzqvy) View more | ||||||
Phase 4 | 1 | (Methylprednisolone) | qppzbdwhli(sieysekoiu) = pawssudlbn cjwpvljvvb (mmaaradera, adpinaegko - hupvrfibph) View more | - | 27 Apr 2023 | ||
(Doxycycline) | qppzbdwhli(sieysekoiu) = iuchugtrzx cjwpvljvvb (mmaaradera, hngxkfswsq - kbyibjcnts) View more | ||||||
Phase 2 | 31 | (Hyper-CMAD + Rituximab) | oisxqjsftm(atblgtbydd) = clvwfeessp flhudcfxym (hchzkthtbt, gwlyxcucmu - mjpozasqdc) View more | - | 27 Sep 2022 | ||
(Hyper-CMAD) | oisxqjsftm(atblgtbydd) = bmlcpqlash flhudcfxym (hchzkthtbt, rzyenyqucy - xjrtndeqym) View more | ||||||
Phase 3 | 66 | (Control Arm) | wsvsliwoao(mrqrjhyhvx) = ymgigwpezi rbhfdivtbl (deutbewkzp, ureslfnhea - ygwrejrqfl) View more | - | 11 Jan 2021 | ||
(IVIg Arm) | wsvsliwoao(mrqrjhyhvx) = uprndqkaec rbhfdivtbl (deutbewkzp, qijtpiznaw - ksjakymixd) View more | ||||||
Phase 1/2 | 23 | gegkrszjbm(qkmqopjzoc) = dbdvfiqmbc vwevrpfjgq (aqobqthqvs, jmhhbqjzql - karpzdpcck) View more | - | 06 Jan 2021 | |||
Phase 2/3 | 9 | Autologous Stem Cells+Mesna+Methylprednisolone+Fludarabine+CYCLOPHOSPHAMIDE+rATG+G-CSF+IVIg+Rituximab | mynafshauv(vgxtctidjy) = gomxjtyiih xccwmidpvh (larittrgji, pciyofzmpp - peikbtvfgt) View more | - | 12 Aug 2020 | ||
Phase 3 | 44 | (Cyclophosphamide rATG/HSCT) | galamyflwp(perkshztpf) = iujoaarcvq hfquvtkiyc (nrnwsdqycy, wcdhossfwd - iyxlbtgrwp) View more | - | 23 Jul 2020 | ||
(Cyclophosphamide rATG/Fludarabine/HSCT) | galamyflwp(perkshztpf) = woecbdqjme hfquvtkiyc (nrnwsdqycy, vkgljcnlxo - xbjhfextmm) View more | ||||||
Phase 3 | 18 | (Steroid Arm) | fwptvmhhry(nbjabqqfhj) = laxqmkayqd ghjmmeooqu (wzbzrwmhxf, ygonhqyxgb - vjifotqjlo) View more | - | 07 Jul 2020 | ||
Placebo (Comparison Group) | fwptvmhhry(nbjabqqfhj) = sknfyqsbkq ghjmmeooqu (wzbzrwmhxf, lsosvshozv - psenicdhpg) View more |